Skip to main content

Advertisement

SpringerLink
Log in

Ocular involvement in Adamantiades-Behçet’s disease in Berlin, Germany

  • Inflammatory Disorders
  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

Abstract

Background

Epidemiological studies demonstrate a prevalence of Adamantiades-Behçet’s disease (ABD) in the range of 0.12–420 per 100,000 inhabitants, with the highest rates in Istanbul, Turkey, and the lowest rates in the USA. Ophthalmological data on the prevalence of ocular involvement are limited for ABD in Germany, because most epidemiological studies are based on rheumatological or dermatological data. Berlin is the city with the highest number of non-native German inhabitants, and its multi-ethnic character renders it uniquely appropriate for epidemiological studies on ABD.

Methods

We retrospectively analyzed all ABD patients seen in our department since 1982. All patients fulfilled the criteria of the International Study Group for Behçet’s Disease. We found 140 patients (63 female, 77 male), with a mean follow-up of 6.4 years (0.5–22 years).

Results

The mean age was 23 at the first manifestation and 32 when the full-blown disease was noted. The mean age at onset of ocular involvement was 30. Most of the patients were of Turkish (n = 73) or German (n = 34) origin. Fifty-six percent developed ocular involvement, which was the first manifestation in 8.6% and the second manifestation in 19.3% of cases.

Conclusions

More than half the patients developed ocular involvement. The calculated prevalence of ocular involvement in ABD is 1.77/100,000 inhabitants for the municipality of Berlin.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Zouboulis CC, May T (2003) Pathogenesis of Adamantiades-Behcet’s disease. Med Microbiol Immunol 192:149–155 doi:10.1007/s00430-002-0167-5

    Article  PubMed  CAS  Google Scholar 

  2. Kotter I, Vonthein R, Muller CA, Gunaydin I, Zierhut M, Stubiger N (2004) Behcet’s disease in patients of German and Turkish origin living in Germany: a comparative analysis. J Rheumatol 31:133–139

    PubMed  Google Scholar 

  3. Krause L (2005) Adamantiades-Behcet’s disease. Ophthalmologe 102:329–334 doi:10.1007/s00347-004-1166-2

    Article  PubMed  CAS  Google Scholar 

  4. Zouboulis CC (1999) Epidemiology of Adamantiades-Behcet’s disease. Ann Med Interne (Paris) 150:488–498

    CAS  Google Scholar 

  5. Papoutsis NG, Abdel-Naser MB, Altenburg A et al (2006) Prevalence of Adamantiades-Behçet’s disease in Germany and the municipality of Berlin: Results of a nationwide survey. Clin Exp Rheumatol 24(suppl 42):S125, Erratum in Clin Exp Rheumatol (2007) 25:507–508

    PubMed  CAS  Google Scholar 

  6. Altenburg A, Papoutsis N, Orawa H, Martus P, Krause L, Zouboulis CC (2006) Epidemiology and clinical manifestations of Adamantiades-Behcet disease in Germany - current pathogenetic concepts and therapeutic possibilities. J Dtsch Dermatol Ges 4:49–64, quiz 65–66 doi:10.1111/j.1610-0387.2006.05841.x

    PubMed  Google Scholar 

  7. International Study Group for Behcet’s Disease (1990) Criteria for diagnosis of Behcet’s disease. Lancet 335:1078–1080

    Google Scholar 

  8. Azizlerli G, Kose AA, Sarica R et al (2003) Prevalence of Behcet’s disease in Istanbul, Turkey. Int J Dermatol 42:803–806 doi:10.1046/j.1365-4362.2003.01893.x

    Article  PubMed  Google Scholar 

  9. Mishima S, Masuda K, Izawa Y, Mochizuki M, Namba K (1979) The eighth Frederick H. Verhoeff Lecture. presented by Saiichi Mishima, MD Behcet’s disease in Japan: ophthalmologic aspects. Trans Am Ophthalmol Soc 77:225–279

    PubMed  CAS  Google Scholar 

  10. Ando K, Fujino Y, Hijikata K, Izawa Y, Masuda K (1999) Epidemiological features and visual prognosis of Behcet’s disease. Jpn J Ophthalmol 43:312–317 doi:10.1016/S0021-5155(99)00029-5

    Article  PubMed  CAS  Google Scholar 

  11. Hamdan A, Mansour W, Uthman I, Masri AF, Nasr F, Arayssi T (2006) Behcet’s disease in Lebanon: clinical profile, severity and two-decade comparison. Clin Rheumatol 25:364–367 doi:10.1007/s10067-005-0058-4

    Article  PubMed  Google Scholar 

  12. Shahram F, Davatchi F, Nadji A et al (2003) Recent epidemiological data on Behcet’s disease in Iran. The 2001 survey. Adv Exp Med Biol 528:31–36 doi:10.1007/0-306-48382-3_5

    Article  PubMed  CAS  Google Scholar 

  13. Yoshida A, Kawashima H, Motoyama Y et al (2004) Comparison of patients with Behcet’s disease in the 1980s and 1990s. Ophthalmology 111:810–815 doi:10.1016/j.ophtha.2003.07.018

    Article  PubMed  Google Scholar 

  14. Zierhut M, Saal J, Pleyer U, Kotter I, Durk H, Fierlbeck G (1995) Behcet’s disease: epidemiology and eye manifestations in German and Mediterranean patients. Ger J Ophthalmol 4:246–251

    PubMed  CAS  Google Scholar 

  15. Elgin U, Berker N, Batman A (2004) Incidence of secondary glaucoma in behcet disease. J Glaucoma 13:441–444 doi:10.1097/00061198-200412000-00002

    Article  PubMed  Google Scholar 

  16. Tugal-Tutkun I, Onal S, Altan-Yaycioglu R, Huseyin Altunbas H, Urgancioglu M (2004) Uveitis in Behcet disease: an analysis of 880 patients. Am J Ophthalmol 138:373–380 doi:10.1016/j.ajo.2004.03.022

    Article  PubMed  Google Scholar 

  17. Ozdal PC, Ortac S, Taskintuna I, Firat E (2002) Posterior segment involvement in ocular Behcet’s disease. Eur J Ophthalmol 12:424–431

    PubMed  CAS  Google Scholar 

  18. Krist D, Schönherr U, Wenkel H (2000) Adamantiadis-Behcet syndrome: fluorescein angiography and choroid ischemia. Klin Monatsbl Augenheilkd 216:45–50 doi:10.1055/s-2000-10515

    Article  PubMed  CAS  Google Scholar 

  19. Benezra D, Cohen E (1986) Treatment and visual prognosis in Behcet’s disease. Br J Ophthalmol 70:589–592 doi:10.1136/bjo.70.8.589

    Article  PubMed  CAS  Google Scholar 

  20. Gurler A, Boyvat A, Tursen U (1997) Clinical manifestations of Behcet’s disease: an analysis of 2147 patients. Yonsei Med J 38:423–427

    PubMed  CAS  Google Scholar 

  21. Ambresin A, Tran T, Spertini F, Herbort C (2002) Behcet’s disease in Western Switzerland: epidemiology and analysis of ocular involvement. Ocul Immunol Inflamm 10:53–63 doi:10.1076/ocii.10.1.53.10326

    Article  PubMed  CAS  Google Scholar 

  22. Torres RM, Yanez B, Herreras JM, Calonge M (2004) Ocular Behcet disease. Retrospective study. Arch Soc Esp Oftalmol 79:599–603

    PubMed  CAS  Google Scholar 

  23. Chung YM, Yeh TS, Sheu MM et al (1990) Behcet’s disease with ocular involvement in Taiwan: a joint survey of six major ophthalmological departments. J Formos Med Assoc 89:413–417

    PubMed  CAS  Google Scholar 

  24. Muhaya M, Lightman S, Ikeda E et al (2000) Behcet’s disease in Japan and in Great Britain: a comparative study. Ocul Immunol Inflamm 8:141–148 doi:10.1076/0927-3948(200009)8:3;1-K;FT141

    Article  PubMed  CAS  Google Scholar 

  25. Escudier M, Bagan J, Scully C (2006) Number VII Behcet’s disease (Adamantiades syndrome). Oral Dis 12:78–84 doi:10.1111/j.1601-0825.2005.01144.x

    Article  PubMed  CAS  Google Scholar 

  26. Tanaka C, Matsuda T, Hayashi E, Imamura Y, Ozaki S (2003) Clinical manifestations and course of 200 Japanese patients with Behcet’s disease. Adv Exp Med Biol 528:77–79 doi:10.1007/0-306-48382-3_14

    Article  PubMed  CAS  Google Scholar 

  27. Saylan T, Ozarmagan G, Azizlerli G, Ovul C, Oke N (1986) Behcet disease in Turkey. Z Hautkr 61:1120–1122

    PubMed  CAS  Google Scholar 

  28. Zouboulis CC, Turnbull JR, Martus P (2003) Univariate and multivariate analyses comparing demographic, genetic, clinical, and serological risk factors for severe Adamantiades-Behçet’s Disease. In: Zouboulis CC (ed) Adamantiades-Behçet’s Disease. Kluwer/Plenum, London Amsterdam, pp 123–126

    Google Scholar 

  29. Krause L, Köhler AK, Altenburg A et al (2008) Ocular involvement is associated with HLA-B51 in Adamantiades-Behçet’s disease. Eye (Jun):13. Epub ahead of print

Download references

Acknowledgement

The authors would like to thank Dr. Joanne Weirowski for her editorial contribution.

Author information

Authors and Affiliations

  1. Department of Ophthalmology, Charité - Campus Benjamin Franklin, Hindenburgdamm 30, 12200, Berlin, Germany

    Lothar Krause, Anne-Katrin Köhler & Michael H. Foerster

  2. Departments of Dermatology and Immunology, Dessau Medical Center, Dessau, Germany

    Andreas Altenburg, Nestor Papoutsis & Christos C. Zouboulis

  3. Department of Ophthalmology, Campus Virchow-Klinikum, Charité Universitaetsmedizin Berlin, Berlin, Germany

    Uwe Pleyer

  4. Institute of Medical Informatics, Biometry and Epidemiology, Campus Benjamin Franklin, Charité Universitaetsmedizin Berlin, Berlin, Germany

    Andrea Stroux

Authors
  1. Lothar Krause
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anne-Katrin Köhler
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Andreas Altenburg
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Nestor Papoutsis
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Christos C. Zouboulis
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Uwe Pleyer
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Andrea Stroux
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Michael H. Foerster
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lothar Krause.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Krause, L., Köhler, AK., Altenburg, A. et al. Ocular involvement in Adamantiades-Behçet’s disease in Berlin, Germany. Graefes Arch Clin Exp Ophthalmol 247, 661–666 (2009). https://doi.org/10.1007/s00417-008-0983-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00417-008-0983-4

Keywords

Search

Navigation